Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Infinity Pharmaceuticals stock

Learn how to easily invest in Infinity Pharmaceuticals stock.

Infinity Pharmaceuticals is a biotechnology business based in the US. Infinity Pharmaceuticals shares (INFI) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy Infinity Pharmaceuticals stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – INFI. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Infinity Pharmaceuticals stock price (NASDAQ: INFI)

Use our graph to track the performance of INFI stocks over time.

Infinity Pharmaceuticals shares at a glance

Information last updated 2023-02-03.
Latest market close$0.64
52-week range$0.44 - $1.76
50-day moving average $0.58
200-day moving average $0.87
Wall St. target price$5.33
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.52

Buy Infinity Pharmaceuticals stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Infinity Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Infinity Pharmaceuticals price performance over time

Historical closes compared with the close of $0.6352 from 2023-02-02

1 week (2023-01-27) -0.75%
1 month (2023-01-03) 11.44%
3 months (2022-11-03) -47.93%
6 months (2022-08-03) -10.03%
1 year (2022-01-30) N/A
2 years (2021-02-03) -82.83%
3 years (2020-02-03) 1.29
5 years (2018-02-02) 2.01

Infinity Pharmaceuticals financials

Revenue TTM $2.5 million
Gross profit TTM $-30,909,000
Return on assets TTM -40.02%
Return on equity TTM -439.96%
Profit margin 0%
Book value $-0.12
Market capitalisation $56.8 million

TTM: trailing 12 months

Infinity Pharmaceuticals share dividends

We're not expecting Infinity Pharmaceuticals to pay a dividend over the next 12 months.

Have Infinity Pharmaceuticals's shares ever split?

Infinity Pharmaceuticals's shares were split on a 1:4 basis on 12 September 2006. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Infinity Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Infinity Pharmaceuticals shares which in turn could have impacted Infinity Pharmaceuticals's share price.

Infinity Pharmaceuticals share price volatility

Over the last 12 months, Infinity Pharmaceuticals's shares have ranged in value from as little as $0.44 up to $1.76. A popular way to gauge a stock's volatility is its "beta".

INFI.US volatility(beta: 1.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Infinity Pharmaceuticals's is 1.2347. This would suggest that Infinity Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Infinity Pharmaceuticals overview

Infinity Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc.

Frequently asked questions

What percentage of Infinity Pharmaceuticals is owned by insiders or institutions?
Currently 1.25% of Infinity Pharmaceuticals shares are held by insiders and 35.689% by institutions.
When does the fiscal year end for Infinity Pharmaceuticals?
Infinity Pharmaceuticals's fiscal year ends in December.
Where is Infinity Pharmaceuticals based?
Infinity Pharmaceuticals's address is: 1100 Massachusetts Avenue, Cambridge, MA, United States, 02138
What is Infinity Pharmaceuticals's ISIN number?
Infinity Pharmaceuticals's international securities identification number is: US45665G3039
What is Infinity Pharmaceuticals's CUSIP number?
Infinity Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 254675101

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site